The Investigator Databank is a global collaboration between pharmaceutical companies to share investigator information that each company has on file with one another. Investigator Databank aims to reduce administrative burden for investigators and to increase visibility of qualified investigators to research sponsors.
Helps the busy sites like us to use a centralized data bank to timely update the site information. I wish other pharmaceutical companies will also support this effort.
AbbVie, Amgen, AstraZeneca, Janssen, Lilly, Merck & Co, Novartis, Pfizer and UCB.
As a first step, you can search to see if any of the Investigator Databank industry members or DrugDev have a record of you or your site on file.
If found, all you need to do is “opt-in” to start sharing with the Investigator Databank and be taken to your profile where you can view, edit, and comment on information from industry member’s clinical trial management systems.Search for my records
There is no charge to investigators or their institutions to opt-in to the Investigator Databank and to create a profile. Industry member companies share the financial support for development and access to the Databank.
Member pharma companies benefit from the following: